141 results
8-K
EX-99.1
DVAX
Dynavax Technologies Corp.
8 May 24
Dynavax Reports First Quarter 2024 Financial Results
4:05pm
Vaccine (Recombinant), Adjuvanted]
HEPLISAV-B vaccine is the first and only adult hepatitis B vaccine approved in the U.S., the European Union … is approved in the U.S., the European Union and Great Britain for the prevention of infection caused by all known subtypes of hepatitis B virus
8-K
EX-99.1
DVAX
Dynavax Technologies Corp.
22 Feb 24
Dynavax Reports Fourth Quarter and Full Year 2023 Financial Results
4:05pm
is the first and only adult hepatitis B vaccine approved in the U.S., the European Union and Great Britain that enables series completion with only two … Vaccine (Recombinant), Adjuvanted], which is approved in the U.S., the European Union and Great Britain for the prevention of infection caused by all
8-K
EX-99.1
y3wntu5vxv2jjjz4
8 Jan 24
Dynavax Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Financial Highlights
9:05am
8-K
EX-99.1
4e9hibt4qqdkc
2 Nov 23
Dynavax Reports Third Quarter 2023 Financial Results and Raises Full Year Revenue Guidance
4:10pm
S-3ASR
603ikid4hj4tdmbv7
3 Aug 23
Automatic shelf registration
5:26pm
8-K
EX-99.1
jwa64tdwd2
3 Aug 23
Dynavax Reports Second Quarter 2023 Financial Results and Raises Full Year Revenue Guidance
4:11pm
8-K
EX-99.1
vsnqeazgfx ykimpu
2 May 23
Dynavax Reports First Quarter 2023 Financial Results
4:11pm
8-K
EX-99.1
ytpamjjrs gv
3 Nov 22
Dynavax Reports Third Quarter 2022 Financial Results
4:10pm
8-K
EX-99.1
hstdw 4n5
4 Aug 22
Dynavax Reports Second Quarter 2022 Financial Results
4:09pm
8-K
EX-99.1
l7fk 4kwq
5 May 22
Dynavax Reports First Quarter 2022 Financial Results
4:04pm